fDi Markets Newswire:

View-from-Bio-2015-what-the-representatives-said

View from Bio 2015: what the representatives said

The Bio International Convention in Philadelphia attracted thousands of visitors from the world of biotech. Michal Kaczmarski spoke to representatives from a number of locations keen to catch the attention of would-be investors in this lucrative field to find out what makes their country stand out.

Thailand pharma

Thailand's new lease of life

Thailand's expertise in the life sciences sector has long remained under the radar, with a lack of investment preventing many of the discoveries from its scientific community making it to the commercial stage. But a government entity, the Thailand Centre for Excellence for Life Sciences, is looking to change this.

biopharma

Biotech-pharma hotspots on the up

Locations are taking advantage of the growing demand for healthcare, bringing together academia, big industry, start-ups, hospitals and sources of capital to create thriving specialised biomedical-pharmaceutical clusters.

Think Tank

Think Tank: how to stay one step ahead of an outbreak

Building an innovation culture can help countries prepare for the outbreak of diseases such as Ebola, write Rachel Chu and Meir Pugatch of Pugatch Consilium.

Lublin looks to make new history

Lublin looks to make new history

Steeped in history, the Polish city of Lublin had fallen upon hard times in the 20th century. However, its 2013 to 2020 strategy plan is already reaping dividends in positioning the city as a centre of business, investment and entrepreneurship within easy reach of both Warsaw and neighbouring Ukraine.

Alabama targets in hi-tech sectors

Alabama has already made a name for itself when it comes to attracting manufacturing investment, but can it repeat this success in the hi-tech sector?

IPAs key to FDI success: Frost & Sullivan

In a recent report, global consultancy Frost & Sullivan outlined the crucial but difficult role that investment promotion agencies play in attracting FDI. 

Alvogen benefits from bio diversity

Alvogen benefits from bio diversity

The rapid growth of Alvogen is impressive by any standards, but for a company operating in the ever-changing pharmaceuticals market it is even more remarkable. The secret of Alvogen's success lies in its decision to expand and diversify its company function, its product line and its geographical markets.

Global M&A activity surpassing 2013: Mergermarket

A third quarter report by data provider Mergermarket shows that deal value in the four months has exceeded that seen in the same quarter of 2013.

Bio International Convention

Bio International Convention: the battle for bio heats up

This year's Bio International Convention attracted more than 15,000 attendees, among them an army of economic developers and elected officials hoping to secure investments into the sector. Michal Kaczmarski asked representatives why investors should bet on their locations and whether they see emerging markets as a source of opportunities or competition.

fDi Tools

fDi Intelligence has a portfolio of related products that enable you to get the targeted foreign investment information you need for your role: 

fdimarkets

For real-time crossborder greenfield investment data on all sectors and locations, click here

fdibenchmark

To benchmark locations for investment projects, click here

fdireports

For bespoke reports on companies, locations or sectors, click here